Results of a real-world study on vortioxetine in patients with major depressive disorder in South East Asia (REVIDA).
CONCLUSION: In real-world clinical settings, vortioxetine was effective in reducing depression severity and improving cognitive function and work productivity in SEA patients with major depression.
PMID: 29768955 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research
More News: Depression | Malaysia Health | Philippines Health | Research | Singapore Health | Study | Thailand Health